Skip to main content
logo
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
41.36
+1.79 (4.52%)
At close: Jul 30, 2026, 4:00 PM EDT
41.48
+0.12 (0.29%)
After-hours: Jul 30, 2026, 7:51 PM EDT

Cogent Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7,0696,4771,0535061,042376
Market Cap Growth
328.02%515.35%107.85%-51.41%177.29%3.46%
Enterprise Value
6,4415,904893.57319.59868.41244.73
Last Close Price
41.3635.527.805.8811.568.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
13.0110.184.111.964.081.75
P/TBV Ratio
9.607.203.161.822.661.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.370.060.070.070.00
Net Debt / Equity Ratio
-1.03-1.04-1.05-0.96-0.94-1.01
Net Debt / EBITDA Ratio
1.762.010.991.211.692.94
Net Debt / FCF Ratio
2.192.491.291.581.913.58
Quick Ratio
14.9414.085.156.969.6612.86
Current Ratio
15.1414.235.327.099.8713.04
Return on Equity (ROE)
-56.96%-73.70%-99.54%-74.94%-59.69%-32.20%
Return on Assets (ROA)
-39.34%-52.68%-86.05%-67.77%-55.48%-31.28%
Return on Invested Capital (ROIC)
-1307.35%-1079.02%-716.32%-511.88%-602.81%-761.64%
Return on Capital Employed (ROCE)
-42.13%-58.19%-100.81%-75.79%-60.47%-33.37%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-6.75%-24.11%-30.38%-35.61%-51.66%-249.52%
Total Shareholder Return
-6.75%-24.11%-30.38%-35.61%-51.66%-249.52%
SEC Filings: 10-K · 10-Q